Company / Named in our posts
Kalaris Tx, Inc..
Follow Kalaris Tx, Inc.Clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases.[1]
01Deal
Deals on Carrywatch
Every deal that names Kalaris Tx, Inc., and its role in each.
AlloVir, Inc. / Kalaris Tx, Inc. (formerly Kalaris Therapeutics, Inc.)
AlloVir and Kalaris Tx complete merger, forming a biopharmaceutical company focused on retinal diseases
See deal detailsDeal Web
Kalaris Tx, Inc. and 0 firms it shares a posted deal with, and the path to any other firm.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Exhibit 99.2 — Risk Factors
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
- 02Form 8-K — Current Report
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Kalaris Tx, Inc.:
- P01